Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Al Amal Group is a leading pharmaceutical and healthcare conglomerate based in Yemen, serving as a major hub for drug distribution and manufacturing in the Middle East. The group operates Al Amal Pharmaceutical Industries, which produces a broad portfolio of generic medicines, and Al Amal Group for Medicines and Medical Supplies, which manages the distribution of products from global pharmaceutical leaders. Their business model encompasses the entire value chain from manufacturing and quality control to large-scale logistics and retail. The company is dedicated to improving healthcare access in the region through the provision of affordable generics and the distribution of specialized medical equipment and laboratory diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alamal Group.